Titan Pharmaceuticals, Inc.

Navigate Titan Pharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Who We Are
    • IP Portfolio
    • Management Team
    • Board of Directors
    • Careers
  • Technology
  • Pipeline
    • Kappa Opioid Receptor Agonist
    • Nalmefene Implant
  • News
    • Overview
    • Press Releases
    • Events
    • Presentations
    • In the News
    • Publications
    • Posters
    • Media Resources
  • Investors
    • Investor Relations
    • Overview
    • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
    • Company Info
    • Company Information
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
    • Titan FCOI Policy
    • Stock Data
    • Quote
    • Charts
    • Historical Data
    • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Contact
  • Search

Press Releases

  • Home
  • Investors
  • News / Events
  • Press Releases
Investors

Navigate Investors

  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Information
  • Stock Data
  • SEC Filings
  • Corporate Governance
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed

Press Releases

  • All News
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009

Titan Reports Third Quarter 2010 Fanapt® Royalty

October 25, 2010

Titan Pharmaceuticals Announces Journal of the American Medical Association Publication of Phase 3 Probuphine™ Data

October 12, 2010

Titan Pharmaceuticals Completes $5 Million Loan

September 28, 2010

Titan Reports Completion of Patient Enrollment in Phase 3 Study of Probuphine™

September 22, 2010

Titan Pharmaceuticals Announces Second Quarter 2010 Financial Results

August 16, 2010

Titan Reports Patient Enrollment in Phase III Study of Probuphine® is Ahead of Schedule

August 3, 2010

Titan Receives SBIR Grant to Investigate Long Term Treatment for Parkinson's Disease

July 26, 2010

Titan Reports Second Quarter 2010 Fanapt® Royalty

July 23, 2010

Probuphine(R) Patent Issued by the U.S. Patent and Trademark Office

June 16, 2010

Titan Stock Commences Trading on the OTCBB

June 2, 2010

RSS
  • « Previous
  • 1...
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • Next »
© 2022 Titan Pharmaceuticals, Inc. All Rights Reserved.
Privacy Policy Titan FCOI Policy Disclaimer Sitemap